MC
Michael E Cahr
Director

Michael E Cahr insider trades: Pacifichealth Laboratories (PHLI) stock buys and sales

Director, Pacifichealth Laboratories Last trade May 11, 2011 41 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2006
5
Companies
last trade 2011

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 11, 2011PHLI↑ Buy$50K
Mar 9, 2011MDF↓ Sell$863K
May 14, 2009MMUS↑ Buy$14K
Aug 15, 2007LIFC↓ Sell$1.3M
Jan 5, 2007PHLI↑ Buy$95K
Aug 31, 2006LIFC↓ Sell$303K
Aug 21, 2006LIFC↓ Sell$291K
Aug 4, 2006MPOW↓ Sell$134K
Mar 7, 2006PHLI↑ Buy$15K
Feb 23, 2006PHLI↑ Buy$20K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael E Cahr's insider trades

Michael E Cahr is a director at Pacifichealth Laboratories (PHLI). Since Feb 23, 2006, Michael has reported 5 open-market purchases worth $194K and 5 sales worth $2.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (22 filings), option exercises (5 filings), shares returned to the company (4 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHLI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.